Navitus Health Solutions

We are thrilled to share that Sharon Faust, Chief Pharmacy Officer at Navitus, has been awarded the PBMI Innovator Award by Managed Healthcare Executive and Pharmacy Benefit Management Institute. This is a well-deserved recognition of her outstanding contributions to the pharmacy benefit management (PBM) industry. This award honors individuals who are driving meaningful change and delivering measurable results, bringing fresh insight and intelligence to the industry. Sharon has done exactly that – challenging the status quo, leading with vision and delivering impact that matters. In her years at Navitus, Sharon has spent over a decade building and managing Lumicera Health Services, one of the first cost-plus pharmacies in the nation, and championing transparency and PBM reform through policy advocacy and industry leadership. Under her leadership, Navitus has consistently controlled prescription drug cost trends, implementing lowest-net-cost and biosimilar strategies to help clients have clarity to actual drug costs and the value of their benefit. Please join us in congratulating Sharon for this incredible achievement and for setting a high bar on PBM innovation. Learn more about Sharon’s award: https://xmrrwallet.com/cmx.pow.ly/jwck50Wzzta #PBMIInnovator #Leadership #PBM

Everyone feels the pressure of rising drug costs, but there are solutions. Last week, Navitus Health Solutions, a transparent PBM and ACHP partner, released its 2024 Drug Trend Report. Key findings include:   • GLP-1s are driving cost and utilization increases • Biosimilars delivered $315M in savings • Dupixent is accounting for 96% of growth in specialty dermatology    ACHP supports solutions that prioritize transparency, lower net costs and clinically-sound utilization. Check out the full 2024 Drug Trend Report here: https://xmrrwallet.com/cmx.plnkd.in/ezjJPVHs. Thanks to Ryan Schmidt & Imke Scheepers for the great presentation. 

In pharmacy benefit management (PBM) contracting, precision matters. When key terms like "rebate", "discount" or "admin fee" are loosely defined or inconsistently used, it becomes difficult for clients to evaluate financial outcomes or hold partners accountable. At Navitus, clarity is built into our approach. We use consistent, well-defined terms in every contract to eliminate confusion and support transparency at every level of benefit design. Discover why contract language - among other factors - is a critical driver of PBM transparency in our latest blog: https://xmrrwallet.com/cmx.pow.ly/QvNn50Wy7T8

Transparency took center stage in Michigan last week — and Navitus was proud to participate in the conversation. At the 40th Annual Michigan Association of Health Plans (MAHP) Conference, Navitus Channel Partner Relationships Manager, Abigail Kraft, offered a closer look at the drug spend and utilization trends shaping pharmacy costs today and how our model is helping Michigan plans manage costs without compromising care. While the industry saw an 11.4% increase in drug spending in 2024, Navitus successfully held overall drug trend to just 7.0%, with 30% of our commercial clients experiencing a negative net total cost trend. What made the difference? Biosimilar conversions, aligned specialty pharmacy support and a 100% pass-through model that puts transparency first. If your PBM can’t show you the full picture, maybe it’s time to rethink your pharmacy benefit strategy. Contact us at sales@navitus.com to explore how we can help.

A transparent pharmacy benefit manager (PBM) should make it easy to understand where its revenue comes from. Yet in many traditional models, rebates are retained, spread pricing is used and fees are hidden - all of which increase costs for plan sponsors. At Navitus, we keep it simple: no hidden fees, no retained revenue, no surprises. Just measurable, transparent performance that keeps clients in control of their pharmacy benefits. Think your PBM is truly transparent? Learn how to evaluate it in our latest blog: https://xmrrwallet.com/cmx.pow.ly/QTNO50WuJZG

The increase in costs for specialty drugs underscores the urgent need for your pharmacy benefits plan to manage specialty costs effectively. Discover actionable insights in our 9th annual Drug Trend Report: https://xmrrwallet.com/cmx.pow.ly/BGmy50WtBOm #SpecialtyPharmacy #PharmacyBenefits #DrugTrendReport

Employers in the 5,000 members or less size range are often underserved by their pharmacy benefit manager (PBM). Meanwhile, just one employee with a high-price prescription can make plan costs skyrocket. We offer the Navitus Key solution, specifically designed for this market segment, to help control rising costs with industry-leading programs and high-touch services. Employers who implement our Navitus Key solution receive unmatched PBM expertise, cost-savings and support. Our 2024 client satisfaction survey results highlighted a 100% client satisfaction rate, with post-implementation surveys showing 100% of clients were satisfied with the transition process. Ready to learn more about how our Navitus Key solution could benefit your organization? Visit https://xmrrwallet.com/cmx.pow.ly/27Xr50WsUni.

We’re excited to return to Michigan Association of Health Plans 2025 to share how our transparent, 100% pass-through model is helping Michigan health plans take control of rising drug costs while improving member outcomes. From eliminating spread pricing to giving full visibility into cost, our model is designed to support smarter pharmacy benefit decisions without compromising quality of care. Curious to learn more? Stop by Navitus booth X to connect with our team and join us for a 10-minute session on July 24, at 8:45 a.m. Plus, don’t miss your chance to spin the wheel for our Nintendo® Switch™ 2 + Mario Kart™ World bundle giveaway! #MAHP2025

Prescription drug spending rose by 11.4% in 2024 — and that growth isn’t slowing down. For decision-makers, understanding what’s driving this trend is more important than ever. Join Navitus clinical experts, Ryan Schmidt, PharmD, and Imke Scheepers, PharmD, on Tuesday, July 29, at 3:00 p.m. EST, for a live webinar exploring key findings from our 2024 Drug Trend Report. They will share timely insights into current drug cost and utilization trend drivers, the growing role of biosimilars, GLP-1 coverage strategies and the evolving specialty dermatology landscape. Secure your spot and register today to stay ahead of the emerging trends: https://xmrrwallet.com/cmx.pow.ly/XT3N50WqQmz

In recent years, “transparency” has become one of the most overused terms in the pharmacy benefit management (PBM) industry. It sounds good, but too often, it’s left undefined or used as a placeholder for promises that don’t hold up under scrutiny. Some PBMs offer partial transparency, leaving hidden revenue streams or vague contract terms in place. For plan sponsors and consultants, this raises an important question: How can you tell if your PBM’s version of transparency delivers its promises? Learn how you can evaluate whether your PBM is truly transparent — or just checking a box — in our latest blog: https://xmrrwallet.com/cmx.pow.ly/Ylpa50WqzMn.